Personalizing prenatal care using family health history: Identifying a panel of conditions for a novel electronic genetic screening tool

Personalized Medicine

Volumn 10, Issue 3, 2013, Pages 307-318

  Lin, Bruce K ^a   Edelman, Emily ^b   McInerney, Joseph D ^b   O'leary, James ^c   Edelson, Vaughn ^c   Hughes, Kevin S ^d   Drohan, Brian ^d   Kyler, Penny ^e   Lloyd Puryear, Michele ^f   Scott, Joan ^b   Dolan, Siobhan M ^a  

^a March of Dimes Birth Defects Foundation   (United States)

^b National Coalition for Health Professional Education in Genetics   (United States)

^c GENETIC ALLIANCE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e HEALTH RESOURCES AND SERVICES ADMINISTRATION   (United States)

^f medical consultant   (United States)

Author keywords

clinical decision support; family health history; genetic screening; personalized risk assessment; prenatal care

Indexed keywords

ARTICLE; BIRTH DEFECT; CARDIOVASCULAR DISEASE; DECISION SUPPORT SYSTEM; FAMILY HISTORY; GENETIC SCREENING; HEMOPHILIA; NEWBORN DISEASE; PERSONALIZED MEDICINE; POINT OF CARE TESTING; PRACTICE GUIDELINE; PRENATAL CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK ASSESSMENT; SEIZURE; SPINAL MUSCULAR ATROPHY;

EID: 84877587599     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/pme.13.18     Document Type: Article

References (73)

1. Beery TA, Shooner KA. Family history: the first genetic screen. Nurse Pract. 29(11), 14-25 (2004).
2. Guttmacher AE, Collins FS, Carmona RH. The family history-more important than ever. N. Engl. J. Med. 351(22), 2333-2336 (2004).
3. Yoon PW, Scheuner MT, Khoury MJ. Research priorities for evaluating family history in the prevention of common chronic diseases. Am. J. Prev. Med. 24(2), 128-135 (2003).
4. Hinton RB Jr. The family history: reemergence of an established tool. Crit. Care Nurs. Clin. North Am. 20(2), 149-158 (2008).
5. US Department of Health and Human Services. Genetics Education and Training: a Report of the Secretary's Advisory Committee on Genetics, Health, and Society. US Department of Health and Human Services, Washington, DC, USA (2011).
6. Wilson BJ, Torrance N, Mollison J et al. Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions. Health Technol. Assess. 9(3), iii-iv, 1-126 (2005).
7. Rich EC, Burke W, Heaton CJ et al. Reconsidering the family history in primary care. J. Gen. Intern. Med. 19(3), 273-280 (2004).
8. Suther S, Goodson P. Barriers to the provision of genetic services by primary care physicians: a systematic review of the literature. Genet. Med. 5(2), 70-76 (2003).
9. Feero WG, Bigley MB, Brinner KM. New standards and enhanced utility for family health history information in the electronic health record: an update from the American Health Information Community's Family Health History Multi-Stakeholder Workgroup. J. Am. Med. Inform. Assoc. 15(6), 723-728 (2008).
10. Melton GB, Raman N, Chen ES, Sarkar IN, Pakhomov S, Madoff RD. Evaluation of family history information within clinical documents and adequacy of HL7 clinical statement and clinical genomics family history models for its representation: a case report. J. Am. Med. Inform. Assoc. 17(3), 337-340 (2010).
11. American College of Obstetricians and Gynecologists Committee on Genetics. ACOG Committee Opinion No. 486: update on carrier screening for cystic fibrosis. Obstet. Gynecol. 117(4), 1028-1031 (2011).
12. NIH. Genetic testing for cystic fibrosis. National Institutes of Health Consensus Development Conference Statement on genetic testing for cystic fibrosis. Arch. Intern. Med. 159(14), 1529-1539 (1999).
13. Watson MS, Cutting GR, Desnick RJ et al. Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet. Med. 6(5), 387-391 (2004).
14. American College of Obstetricians and Gynecologists Committee on Genetics. ACOG Committee Opinion. Number 318, October 2005. Screening for Tay-Sachs disease. Obstet. Gynecol. 106(4), 893-894 (2005).
15. ACOG Committee on Obstetrics. ACOG Practice Bulletin No. 78: hemoglobinopathies in pregnancy. Obstet. Gynecol. 109(1), 229-237 (2007).
16. American College of Obstetricians and Gynecologists Committee on Genetics. Committee Opinion No. 478: family history as a risk assessment tool. Obstet. Gynecol. 117(3), 747-750 (2011).
17. Scheuner MT, Wang SJ, Raffel LJ, Larabell SK, Rotter JI. Family history: a comprehensive genetic risk assessment method for the chronic conditions of adulthood. Am. J. Med. Genet. 71(3), 315-324 (1997).
18. Harrison TA, Hindorff LA, Kim H et al. Family history of diabetes as a potential public health tool. Am. J. Prev. Med. 24(2), 152-159 (2003).
19. Carmona RH, Wattendorf DJ. Personalizing prevention: the US Surgeon General's Family History Initiative. Am. Fam. Physician 71(1), 36-39 (2005).
20. O'Leary J, Edelson V, Gardner N et al. Community-centered family health history: a customized approach to increased health communication and awareness. Prog. Community Health Partnersh. 5(2), 113-122 (2011).
21. Dolan SM, Moore C. Linking family history in obstetric and pediatric care: assessing risk for genetic disease and birth defects. Pediatrics 120(Suppl. 2), S66-S70 (2007).
22. Valdez R, Yoon PW, Qureshi N, Green RF, Khoury MJ. Family history in public health practice: a genomic tool for disease prevention and health promotion. Annu. Rev. Public Health 31, 69-87 (2010).
23. Berg AO, Baird MA, Botkin JR et al. National Institutes of Health State-of-the-Science Conference Statement: Family History and Improving Health: August 24-26, 2009. NIH Consens. State. Sci. Statements 26(1), 1-19 (2009).
24. Rubinstein WS, Acheson LS, O'Neill SM et al. Clinical utility of family history for cancer screening and referral in primary care: a report from the Family Healthware Impact Trial. Genet. Med. 13(11), 956-965 (2011).
25. Qureshi N, Dhiman P, Kai J. Adding systematic family history enquiry to cardiovascular disease risk assessment: clinical utility in primary care. Ann. Intern. Med. 157(2), 149 (2012).
26. Darcy D, Tian L, Taylor J, Schrijver I. Cystic fibrosis carrier screening in obstetric clinical practice: knowledge, practices, and barriers, a decade after publication of screening guidelines. Genet. Test. Mol. Biomarkers 15(7-8), 517-523 (2011).
27. Morgan MA, Driscoll DA, Zinberg S, Schulkin J, Mennuti MT. Impact of self-reported familiarity with guidelines for cystic fibrosis carrier screening. Obstet. Gynecol. 105(6), 1355-1361 (2005).
28. Bradley LA, Kloza EM, Haddow PK, Beauregard LJ, Johnson JL, Haddow JE. A genetic history questionnaire-based system in primary prenatal care to screen for selected fetal disorders. Genet. Test 11(3), 291-295 (2007).
29. Yoon PW, Scheuner MT, Jorgensen C, Khoury MJ. Developing Family Healthware, a family history screening tool to prevent common chronic diseases. Prev. Chronic Dis. 6(1), A33 (2009).
30. Orlando LA, Hauser ER, Christianson C et al. Protocol for implementation of family health history collection and decision support into primary care using a computerized family health history system. BMC Health Serv. Res. 11, 264 (2011).
31. Owens KM, Marvin ML, Gelehrter TD, Ruffin MT 4th, Uhlmann WR. Clinical use of the Surgeon General's "My Family Health Portrait" (MFHP) tool: opinions of future health care providers. J. Genet. Couns. 20(5), 510-525 (2011).
32. Reid GT, Walter FM, Brisbane JM, Emery JD. Family history questionnaires designed for clinical use: a systematic review. Public Health Genomics 12(2), 73-83 (2009).
33. Wilson BJ, Carroll JC, Allanson J et al. Family history tools in primary care: does one size fit all? Public. Health. Genomics 15(3-4), 181-188 (2012).
34. American College of Obstetricians and Gynecologists Committee on Genetics. Committee opinion no. 469: carrier screening for fragile X syndrome. Obstet. Gynecol. 116(4), 1008-1010 (2010).
35. Gross J, Pletcher B, Monaghan K. ACMG practice guidelines: carrier screening in individuals of Ashkenazi Jewish descent. Genet. Med. 10(1), 54-56 (2008).
36. American College of Obstetricians and Gynecologists Committee on Genetics. ACOG Committee Opinion No. 442: preconception and prenatal carrier screening for genetic diseases in individuals of Eastern European Jewish descent. Obstet. Gynecol. 114(4), 950-953 (2009).
37. American College of Obstetricians and Gynecologists Committee on Genetics. ACOG Committee Opinion No. 432: spinal muscular atrophy. Obstet. Gynecol. 113(5), 1194-1196 (2009).
38. Prior TW. Carrier screening for spinal muscular atrophy. Genet. Med. 10(11), 840-842 (2008).
39. ACOG. ACOG Practice Bulletin No. 103: hereditary breast and ovarian cancer syndrome. Obstet. Gynecol. 113(4), 957-966 (2009).
40. American College of Obstetricians and Gynecologists. ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001. (Replaces technical bulletin number 212, September 1995).
41. American College of Obstetricians and Gynecologists. ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001. (Replaces technical bulletin number 212, September 1995). American College of Obstetricians and Gynecologists. Int. J. Gynaecol. Obstet. 78(2), 179-190 (2002).
42. ACMG. Genetics Evaluation Guidelines for the Etiologic Diagnosis of Congenital Hearing Loss. Genetic Evaluation of Congenital Hearing Loss Expert Panel. ACMG statement. Genet. Med. 4(3), 162-171 (2002).
43. American College of Obstetricians and Gynecologists, Women's Health Care Physicians. ACOG practice bulletin. Osteoporosis. Clinical management guidelines for obstetrician-gynecologists. Number 50, January 2003. Obstet. Gynecol. 103(1), 203-216 (2004).
44. American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Obstetrics: practice bulletin no 130: prediction and prevention of preterm birth. Obstet. Gynecol. 120(4), 964-973 (2012).
45. American College of Obstetricians and Gynecologists Committee on Adolescent Health Care; American College of Obstetricians and Gynecologists Committee Gynecologic Practice. ACOG Committee Opinion No. 451: von Willebrand disease in women. Obstet. Gynecol. 114(6), 1439-1443 (2009).
46. American College of Obstetricians and Gynecologists Committee on Genetics. ACOG committee opinion no. 449: maternal phenylketonuria. Obstet. Gynecol. 114(6), 1432-1433 (2009).
47. Committee on Practice Bulletins-Gynecology, American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 84: prevention of deep vein thrombosis and pulmonary embolism. Obstet. Gynecol. 110(2 Pt 1), 429-440 (2007).
48. Cheschier N; ACOG Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin. Neural tube defects. Number 44, July 2003. (Replaces committee opinion number 252, March 2001). Int. J. Gynaecol. Obstet. 83(1), 123-133 (2003).
49. American College of Obstetricians and Gynecologists Committee on Practice Bulletins-obstetrics. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001. (Replaces technical bulletin number 200, December 1994). Gestational diabetes. Obstet. Gynecol. 98(3), 525-538 (2001).
50. Bennett RL, Motulsky AG, Bittles A et al. Genetic counseling and screening of consanguineous couples and their offspring: recommendations of the National Society of Genetic Counselors. J. Genet. Couns. 11(2), 97-119 (2002).
51. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 125: chronic hypertension in pregnancy. Obstet. Gynecol. 119(2 Pt 1), 396-407 (2012).
52. Pletcher BA, Toriello HV, Noblin SJ et al. Indications for genetic referral: a guide for healthcare providers. Genet. Med. 9(6), 385-389 (2007).
53. Mosca L, Benjamin EJ, Berra K et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. Circulation 123(11), 1243-1262 (2011).
54. Hemminki K, Li X, Sundquist K, Sundquist J. Familial risks for common diseases: etiologic clues and guidance to gene identification. Mutat. Res. 658(3), 247-258 (2008).
55. American College of Obstetricians and Gynecologists. Committee on Obstetric Practice: committee opinion no. 453: screening for depression during and after pregnancy. Obstet. Gynecol. 115(2 Pt 1), 394-395 (2010).
56. Cohn WF, Ropka ME, Pelletier SL et al. Health Heritage© a web-based tool for the collection and assessment of family health history: initial user experience and analytic validity. Public Health Genomics 13(7-8), 477-491 (2010).
57. Kaplan KD, Brown M, Croughan MS, Turek PJ. The relative accuracy of a questionnaire compared with pedigree analysis in genetic risk assessment for infertility. J. Urol. 179(4), 1499-1505 (2008).
58. Facio FM, Feero WG, Linn A, Oden N, Manickam K, Biesecker LG. Validation of my family health portrait for six common heritable conditions. Genet. Med. 12(6), 370-375 (2010).
59. Welch BM, Kawamoto K. Clinical decision support for genetically guided personalized medicine: a systematic review. J. Am. Med. Inform. Assoc. 20(2), 388-400 (2012).
60. Health Level Seven. HL7 version 3 standard: clinical genomics; pedigree, release 1 (2012). www.hl7.org/implement/standards/product- brief.cfm?product-id= 8
61. US CDC-CDC Family Health History Initiative (2012). www.cdc.gov/genomics/ famhistory/famhist. htm
62. Healthy People 2020. Genomics (2012). www.healthypeople.gov/2020/ topicsobjectives2020/overview. aspx?topicId=15
63. HughesRiskApps (2012). www.hughesriskapps.com
64. National Coalition for Health Professional Education in Genetics (2013). www.nchpeg.org
65. March of Dimes Foundation. Genetics and Your Practice online: Whats New (2013). www.marchofdimes.com/gyponline/index. bm2?cid=00000002&spid=gyp-hp- 1- nologin&tpid=gyp-updates
66. Genetic Alliance (2013). www.geneticalliance.org/fhh.prenatal
67. American College of Obstetricians and Gynecologists-Antepartum Record (2012). www.acog.org
68. American Medical Association-Prenatal Screening Questionnaire (2012). www.ama-assn.org/resources/doc/genetics/ped-screening.pdf
69. March of Dimes Foundation. Genetics and your practice prenatal/preconcpetion family history questionnaire (2012). www.marchofdimes. com/gyponline
70. Genzyme Genetics. Prenatal Genetic Screening Questionnaire. www.genzymegenetics.com
71. LabCorp Specialty Testing Group Integrated Genetics. Family History Questionnaire (2012). www.labcorp.com/wps/wcm/connect/mtolib/Reproductive/Home/ Resources/Family+History+Questionnaire
72. National Coalition for Health Professional Education in Genetics. Pregnancy & Health Profile (2012). www.youtube.com/watch?v=hFauzPctTNk
73. The Noun Project (2012). http://thenounproject.com